HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qiang Ma Selected Research

6-Aminonicotinamide (6 Aminonicotinamide)

2/2022Plumbagin reduction by thioredoxin reductase 1 possesses synergy effects with GLUT1 inhibitor on KEAP1-mutant NSCLC cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qiang Ma Research Topics

Disease

81Neoplasms (Cancer)
03/2022 - 01/2002
26Inflammation (Inflammations)
01/2022 - 01/2002
22Fibrosis (Cirrhosis)
05/2022 - 01/2010
20Neoplasm Metastasis (Metastasis)
04/2022 - 02/2003
13Infections
01/2021 - 12/2010
12Breast Neoplasms (Breast Cancer)
01/2022 - 11/2012
11Carcinogenesis
01/2022 - 07/2007
10Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2017
10Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2004
10Hypoxia (Hypoxemia)
04/2020 - 04/2012
9Gallbladder Neoplasms (Gallbladder Cancer)
04/2022 - 04/2016
8Alzheimer Disease (Alzheimer's Disease)
01/2022 - 08/2008
7Lung Neoplasms (Lung Cancer)
01/2022 - 10/2017
7Prostatic Neoplasms (Prostate Cancer)
05/2021 - 02/2014
7Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 07/2002
7Reperfusion Injury
10/2018 - 08/2005
6Heart Failure
05/2022 - 02/2018
6Carcinoma (Carcinomatosis)
09/2021 - 08/2002
6Myocardial Infarction
01/2021 - 07/2008
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2022 - 09/2015
5Stroke (Strokes)
01/2021 - 07/2008
5Esophageal Squamous Cell Carcinoma
01/2021 - 07/2013
4Urinary Bladder Neoplasms (Bladder Cancer)
03/2022 - 09/2005
4Atherosclerosis
01/2021 - 01/2009
4Necrosis
01/2020 - 03/2016
4Chronic Disease (Chronic Diseases)
01/2019 - 09/2008
4Ischemia
10/2018 - 08/2005
4Poisoning
03/2010 - 08/2005
3Pain (Aches)
05/2022 - 03/2020
3Triple Negative Breast Neoplasms
01/2022 - 01/2020
3Cognitive Dysfunction
01/2022 - 03/2011
3Diabetes Mellitus
10/2021 - 01/2020
3Pancreatic Neoplasms (Pancreatic Cancer)
05/2021 - 09/2017
3Hyperglycemia
01/2021 - 01/2015
3Atherosclerotic Plaque (Atheroma)
01/2021 - 01/2020
3Sleep Deprivation
01/2020 - 03/2010
3Hypertension (High Blood Pressure)
01/2020 - 07/2014
3Pneumonia (Pneumonitis)
01/2020 - 01/2018
3Colonic Neoplasms (Colon Cancer)
10/2018 - 01/2010
3Type 2 Diabetes Mellitus (MODY)
01/2018 - 01/2013
3Leukemia
01/2013 - 02/2009
2Death (Near-Death Experience)
07/2022 - 01/2017

Drug/Important Bio-Agent (IBA)

38Proteins (Proteins, Gene)FDA Link
05/2022 - 02/2008
14Pharmaceutical PreparationsIBA
02/2022 - 09/2008
14CytokinesIBA
02/2021 - 01/2002
12Biological ProductsIBA
03/2022 - 02/2016
12Messenger RNA (mRNA)IBA
05/2021 - 02/2009
12MelatoninIBA
01/2021 - 08/2017
11Reactive Oxygen Species (Oxygen Radicals)IBA
02/2022 - 06/2006
11MicroRNAs (MicroRNA)IBA
01/2022 - 01/2012
11Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2005
11Carbon Nanotubes (Carbon Nanotube)IBA
01/2020 - 04/2015
10Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2009
9CalciumIBA
12/2021 - 08/2002
9AntioxidantsIBA
05/2021 - 01/2002
8EnzymesIBA
02/2022 - 07/2007
7artenimol (dihydroartemisinin)IBA
04/2022 - 01/2017
7Transcription Factors (Transcription Factor)IBA
01/2021 - 06/2006
7Therapeutic UsesIBA
01/2021 - 12/2010
6Small Interfering RNA (siRNA)IBA
11/2018 - 01/2010
6Benzene (Benzole)IBA
01/2013 - 08/2005
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2019 - 01/2002
4Adenosine Triphosphate (ATP)IBA
05/2022 - 04/2020
4AntigensIBA
03/2022 - 11/2006
4GoldIBA
01/2022 - 06/2018
4Hormones (Hormone)IBA
01/2022 - 08/2010
4Circular RNAIBA
12/2021 - 01/2019
4EpitopesIBA
10/2021 - 10/2015
4LipidsIBA
05/2021 - 01/2020
4NF-kappa B (NF-kB)IBA
03/2021 - 11/2003
4CollagenIBA
01/2020 - 02/2016
4InterleukinsIBA
12/2019 - 11/2003
4DNA (Deoxyribonucleic Acid)IBA
11/2018 - 06/2006
4Translationally-Controlled 1 Tumor ProteinIBA
10/2018 - 01/2010
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2009 - 02/2003
3Doxorubicin (Adriamycin)FDA LinkGeneric
05/2022 - 06/2015
3Thioredoxin Reductase 1IBA
02/2022 - 01/2021
3Amyloid (Amyloid Fibrils)IBA
01/2022 - 08/2015
3Immune Checkpoint InhibitorsIBA
01/2022 - 01/2021
3G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
12/2021 - 11/2014
3RNA (Ribonucleic Acid)IBA
11/2021 - 01/2018
3Dinoprostone (PGE2)FDA Link
11/2021 - 11/2018
3TOR Serine-Threonine KinasesIBA
03/2021 - 12/2019
3Interleukin-6 (Interleukin 6)IBA
02/2021 - 10/2016
3Histone DemethylasesIBA
01/2021 - 07/2013
3Oxygen (Dioxygen)IBA
04/2020 - 01/2016
3Urea (Carbamide)FDA LinkGeneric
01/2020 - 09/2013
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2019 - 12/2011
3Metformin (Glucophage)FDA LinkGeneric
11/2019 - 08/2018
3GlycosidesIBA
01/2019 - 04/2016
3Silicon Dioxide (Silica)FDA LinkGeneric
12/2017 - 02/2016
3SurvivinIBA
01/2016 - 09/2005
3VaccinesIBA
10/2015 - 12/2010
3CreatinineIBA
07/2014 - 01/2013

Therapy/Procedure

23Therapeutics
02/2022 - 01/2010
9Drug Therapy (Chemotherapy)
09/2021 - 06/2011
8Moxibustion
05/2022 - 02/2018
8Quantum Dots (Quantum Dot)
12/2021 - 05/2009
7Immunotherapy
01/2022 - 01/2021
3Aftercare (After-Treatment)
11/2019 - 07/2008